Artemisinin derivative tablets for rapid action against multidrug-resistant Plasmodium falciparum in uncomplicated cases. Deployed in outpatient facilities and home-based management in high-burden countries. Procured by global fund initiatives, wholesalers, and endemic nation health systems for first-line therapy.